Structures by: Scott J. S.
Total: 7
C17H17N
C17H17N
Chemical science (2017) 8, 3 1981-1985
a=6.0770(11)Å b=7.7665(14)Å c=27.619(5)Å
α=90° β=90° γ=90°
C42H40Cl2NOPPd,3(CHCl3)
C42H40Cl2NOPPd,3(CHCl3)
Chemical science (2017) 8, 3 1981-1985
a=13.7983(8)Å b=18.7174(11)Å c=19.3028(11)Å
α=90° β=90° γ=90°
AZ12576722, AZ SBBG: 2006-10-306
C18H18BrNO2
MedChemComm (2014) 5, 1 57
a=5.9750(2)Å b=11.6900(3)Å c=23.7850(5)Å
α=90.00° β=90.00° γ=90.00°
Tetrahydrofuran-3-yl 4-(5-((3-cyanopyridin-4-yl) methoxy)pyrimidin-2-yl)piperazine-1-carboxylate
C20H22N6O4
MedChemComm (2013) 4, 1 95
a=5.2885(7)Å b=11.2227(15)Å c=16.881(2)Å
α=85.165(6)° β=83.895(6)° γ=76.853(5)°
4-((2-(4-(5-isopropyl-1,2,4-oxadiazol-3-yl)-2-methylpiperazin- 1-yl)pyrimidin-5-y
C21H20N8O2,3(H)
MedChemComm (2012) 3, 5 600
a=9.1873(3)Å b=10.2806(2)Å c=11.8644(3)Å
α=94.876(1)° β=103.767(2)° γ=102.245(1)°
4-((2-(4-(5-(difluoromethyl)-1,2,4-oxadiazol-3-yl)-2- methylpiperazin-1-yl) pyrimidin-5-yloxy)methyl)nicotinonitrile
C19H18F2N8O2
MedChemComm (2012) 3, 5 600
a=6.8535(17)Å b=11.759(3)Å c=24.167(8)Å
α=90.00° β=90.00° γ=90.00°
C17H18O2
C17H18O2
Journal of the Chemical Society, Perkin Transactions 1 (2000) 24 4366
a=9.538(2)Å b=16.348(4)Å c=8.395(2)Å
α=90° β=90° γ=90°